102 related articles for article (PubMed ID: 34157917)
1. Social and economic burden of breast cancer in the North East region of Bulgaria.
Tsvetkova A; Mihaylova S; Kamusheva M
Expert Rev Pharmacoecon Outcomes Res; 2021 Dec; 21(6):1203-1209. PubMed ID: 34157917
[No Abstract] [Full Text] [Related]
2. [DALYs for breast cancer in China, 2000-2050: trend analysis and prediction based on GBD 2019].
Yan XX; Li YJ; Cao MD; Wang H; Liu CC; Wang X; Ran JC; Liang L; Lei L; Peng J; Shi JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Dec; 42(12):2156-2163. PubMed ID: 34954980
[No Abstract] [Full Text] [Related]
3. Economic and disease burden of breast cancer associated with suboptimal breastfeeding practices in Mexico.
Unar-Munguía M; Meza R; Colchero MA; Torres-Mejía G; de Cosío TG
Cancer Causes Control; 2017 Dec; 28(12):1381-1391. PubMed ID: 28983711
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
5. The burden of disease and the cost of illness attributable to child maltreatment in Japan: long-term health consequences largely matter.
Mo X; Gai RT; Tachibana Y; Bolt T; Takahashi Y; Nakayama T
BMC Public Health; 2020 Aug; 20(1):1296. PubMed ID: 32854682
[TBL] [Abstract][Full Text] [Related]
6. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
Łyszczarz B; Nojszewska E
BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
[TBL] [Abstract][Full Text] [Related]
7. New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria.
Kamusheva M; Vandeva S; Mitov K; Rusenova Y; Elenkova A; Zacharieva S; Mitkova Z; Tachkov K; Dimitrova M; Doneva M; Tcharaktchiev D; Petrova G
Front Public Health; 2020; 8():147. PubMed ID: 32411649
[No Abstract] [Full Text] [Related]
8. An Analysis of the Social and Economic Costs of Breast Cancer in Italy.
Mennini FS; Trabucco Aurilio M; Gazzillo S; Nardone C; Sciattella P; Marcellusi A; Migliorini R; Sciannamea V; Piccioni A; Bolcato M; Barni S
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501588
[TBL] [Abstract][Full Text] [Related]
9. A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China.
Guojun T; Yan X; Weizhi W; Lihua W; Chunyang L; Xinghu Z; Hongyu Z; Huiqing D; Meini Z; Tao J; Huan Y; Liying C; Li G
Mult Scler Relat Disord; 2022 Apr; 60():103732. PubMed ID: 35325723
[TBL] [Abstract][Full Text] [Related]
10. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
Mangen MJ; Bouwknegt M; Friesema IH; Haagsma JA; Kortbeek LM; Tariq L; Wilson M; van Pelt W; Havelaar AH
Int J Food Microbiol; 2015 Mar; 196():84-93. PubMed ID: 25528537
[TBL] [Abstract][Full Text] [Related]
11. Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan.
Luh DL; Liu CC; Luo YR; Chen SC
J Infect Public Health; 2018; 11(2):215-223. PubMed ID: 28757293
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer management: quality-of-life and cost considerations.
Radice D; Redaelli A
Pharmacoeconomics; 2003; 21(6):383-96. PubMed ID: 12678566
[TBL] [Abstract][Full Text] [Related]
13. Economic Burden and Disability-Adjusted Life Years (DALYs) of Attention Deficit/Hyperactivity Disorder.
Hong M; Park B; Lee SM; Bahn GH; Kim MJ; Park S; Oh IH; Park H
J Atten Disord; 2020 Apr; 24(6):823-829. PubMed ID: 31364445
[No Abstract] [Full Text] [Related]
14. Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria.
Kamusheva M; Dimitrova M; van Boven JF; Postma MJ; van der Molen T; Kocks JW; Mitov K; Doneva M; Petrova D; Georgiev O; Petkova V; Petrova G
J Med Econ; 2017 May; 20(5):503-509. PubMed ID: 28058859
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of metastatic breast cancer in Spain.
Bermejo de Las Heras B; Cortes Ramon Y Cajal J; Galve Calvo E; de la Haba Rodriguez J; Garcia Mata J; Moreno Anton F; Pelaez Fernandez I; Rodriguez-Lescure A; Rodriguez Sanchez CA; Ruiz-Borrego M; Remak E; Barra M; Rivero M; Soto Alvarez J
Eur J Hosp Pharm; 2020 Jan; 27(1):19-24. PubMed ID: 32064084
[TBL] [Abstract][Full Text] [Related]
16. Burden of surgical site infections in the Netherlands: cost analyses and disability-adjusted life years.
Koek MBG; van der Kooi TII; Stigter FCA; de Boer PT; de Gier B; Hopmans TEM; de Greeff SC;
J Hosp Infect; 2019 Nov; 103(3):293-302. PubMed ID: 31330166
[TBL] [Abstract][Full Text] [Related]
17. Haemophilia A: health and economic burden of a rare disease in Portugal.
Café A; Carvalho M; Crato M; Faria M; Kjollerstrom P; Oliveira C; Pinto PR; Salvado R; Dos Santos AA; Silva C
Orphanet J Rare Dis; 2019 Sep; 14(1):211. PubMed ID: 31484564
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007-2017.
Huang SY; Chen HM; Liao KH; Ko BS; Hsiao FY
BMJ Open; 2020 Oct; 10(10):e036341. PubMed ID: 33039986
[TBL] [Abstract][Full Text] [Related]
19. The Economic Burden of Breast Cancer in Korea from 2007-2010.
Kim YA; Oh IH; Yoon SJ; Kim HJ; Seo HY; Kim EJ; Lee YH; Jung JH
Cancer Res Treat; 2015 Oct; 47(4):583-90. PubMed ID: 25687860
[TBL] [Abstract][Full Text] [Related]
20. Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness.
Neves M; Trigo F; Rui B; João C; Lúcio P; Mariana N; Mendes J; Pedrosa H; Geraldes C
Pharmacoeconomics; 2021 May; 39(5):579-587. PubMed ID: 33517511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
